Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.

Item

http://www.wikidata.org/entity/Q40929566

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.

@en

type

Item

label

Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.

@en

prefLabel

Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.

@en

P1476

Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect

@en

P2093

Cheng-Ge Gao

http://www.w3.org/2001/XMLSchema#string

Min Jia

http://www.w3.org/2001/XMLSchema#string

Wen-Hui Jiang

http://www.w3.org/2001/XMLSchema#string

Xian-Cang Ma

http://www.w3.org/2001/XMLSchema#string

Xiao-Ling Zhang

http://www.w3.org/2001/XMLSchema#string

Yong-Hui Dang

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular motor toolbox for intracellular transport

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.

Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Nasal drug administration: potential for targeted central nervous system delivery.

NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

Differentiating antidepressants of the future: efficacy and safety.

P2888

s11064-016-1841-0

P304

1375-1380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-016-1841-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zheng Chu

P577

2016-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293044348

http://www.w3.org/2001/XMLSchema#string

P6179

1020080713

http://www.w3.org/2001/XMLSchema#string

P698

26846142

http://www.w3.org/2001/XMLSchema#string